What is driving the pre-market volume in 4564.T stock?

Pre-market interest in 4564.T stock is driven by its clinical pipeline updates and the upcoming earnings announcement on 30 Jan 2026, combined with elevated intraday volume of **38,531,800.00** that attracts momentum traders.

What are the key valuation metrics for 4564.T stock?

Key metrics: market cap **JPY 7,560,158,716.00**, EPS **-2.83**, price-to-sales **7.90** and price-to-book **4.26**. These show elevated valuation versus Healthcare peers and reflect development-stage losses for 4564.T stock.

What price targets does Meyka AI give for 4564.T stock?

Meyka AI's forecast model projects a monthly target of **JPY 28.51** (+29.59% vs **JPY 22.00**) and a yearly target of **JPY 18.22** (-17.27% vs **JPY 22.00**). Forecasts are model-based projections and not guarantees.

How does Meyka AI rate 4564.T stock?

Meyka AI rates 4564.T with a score of **65.41 out of 100** (Grade B, HOLD). The grade considers benchmark and sector comparisons, financial growth, key metrics and analyst context.

JP Stocks

4564.T OncoTherapy Science JPX pre-market most active: JPY 22.00, vol 38.53M catalyst ahead

ByHuzaifa Zahoor January 21, 2026January 21, 2026

Pre-market activity puts OncoTherapy Science, Inc. (4564.T stock) among JPX’s most active names on 22 Jan 2026. The share price is JPY 22.00 with 38,531,800.00 shares traded and intraday range JPY 21.00–22.00. Higher volume follows renewed interest in the clinical pipeline and an upcoming earnings announcement on 30 Jan 2026. Traders should note the mix of stretched technicals and thin float dynamics that can amplify moves in the short term.